COMPARISON OF PSA VALUE AT LAST FOLLOW-UP OF PATIENTS WHO UNDERWENT LOW-DOSE RATE BRACHYTHERAPY AND INTENSITY-MODULATED RADIATION THERAPY FOR PROSTATE CANCER
Tìm thấy 10,000 tài liệu liên quan tới tiêu đề "Comparison of PSA value at last follow-up of patients who underwent low-dose rate brachytherapy and...":
CHAPTER 091. BENIGN AND MALIGNANT DISEASES OF THE PROSTATE (PART 8) DOCX
Chapter 091. Benign and Malignant Diseases of the Prostate (Part 8) For patients with a rising PSA after radiation therapy, salvage prostatectomy can be considered if the disease was "curable" at the outset, if persistent disease has been docu[r]
5 Đọc thêm
NGHIÊN CỨU ỨNG DỤNG SINH THIẾT TUYẾN TIỀN LIỆT 12 MẪU DƯỚI HƯỚNG DẪN CỦA SIÊU ÂM QUA TRỰC TRÀNG TRONG CHẨN ĐOÁN UNG THƯ TUYẾN TIỀN LIỆT (TT ANH)
INTRODUCTION
Prostate cancer is the 2
nd
most common cancer and the 5
th
most
common death rate for men worldwide. The definitive diagnosis should
be based on digital rectal examination (DRE), serum PSA, prostate
biopsy results. Biopsy plays a decisive role in diagnosis of prostate
can[r]
Prostate cancer is the 2
nd
most common cancer and the 5
th
most
common death rate for men worldwide. The definitive diagnosis should
be based on digital rectal examination (DRE), serum PSA, prostate
biopsy results. Biopsy plays a decisive role in diagnosis of prostate
can[r]
24 Đọc thêm
PROGNOSTIC VALUE OF THE DISTANCE BETWEEN THE PRIMARY TUMOR AND BRAINSTEM IN THE PATIENTS WITH LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA
Brainstem dose limitations influence radiation dose reaching to tumor in the patients with locallyadvanced nasopharyngeal cancer (NPC). A retrospective analysis of the prognostic value of the distance between the primary tumor and brainstem (Dbs) in 358 patients with locally-advanced NPC after inten[r]
11 Đọc thêm
ADJUVANT CHEMOTHERAPY FOR STAGE III COLON CANCER: RELATIVE DOSE INTENSITY AND SURVIVAL AMONG VETERANS
Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS).
COST-EFFECTIVENESS ANALYSIS OF PROTON BEAM THERAPY FOR TREATMENT DECISION MAKING IN PARANASAL SINUS AND NASAL CAVITY CANCERS IN CHINA
Cost-effectiveness is a pivotal consideration for clinical decision making of high-tech cancer treatment in developing countries. Intensity-modulated proton radiation therapy (IMPT, the advanced form of proton beam therapy) has been found to improve the prognosis of the patients with paranasal sinus[r]
9 Đọc thêm
COMPARISON OF CERVICAL CANCER SCREENING AMONG WOMEN WITH AND WITHOUT HYSTERECTOMIES: A NATIONWIDE POPULATIONBASED STUDY IN KOREA
Cervical cancer screening is not recommended for women who underwent hysterectomy with no history of cervical intraepithelial neoplasia (CIN) of grade 2 or higher. We aimed to determine the cervical cancer screening rate in Korean women who underwent hysterectomies and compare it to that in women wi[r]
PROSTATE MULTICENTRE EXTERNAL BEAM RADIOTHERAPY USING A STEREOTACTIC BOOST: THE PROMETHEUS STUDY PROTOCOL
High Dose Rate Brachytherapy (HDRB) boost is a well-established treatment for prostate cancer (PC). We describe the PROstate Multicentre External beam radioTHErapy Using Stereotactic boost (PROMETHEUS) study. Non-surgical stereotactic techniques are used to deliver similar doses to HDRB boost regime[r]
RNA-seq profiling of a radiation resistant and radiation sensitive prostate cancer cell line highlights opposing regulation of DNA repair and targets for radiosensitization
Radiotherapy is a chosen treatment option for prostate cancer patients and while some tumours respond well, up to 50% of patients may experience tumour recurrence. Identification of functionally relevant predictive biomarkers for radioresponse in prostate cancer would enable radioresistant patients[r]
LONG-TERM OUTCOMES OF DUCTAL CARCINOMA IN SITU OF THE BREAST: A SYSTEMATIC REVIEW, META-ANALYSIS AND META-REGRESSION ANALYSIS
To summarize data on long-term ipsilateral local recurrence (LR) and breast cancer death rate (BCDR) for patients with ductal carcinoma in situ (DCIS) who received different treatments. Methods: Systematic review and study-level meta-analysis of prospective (n = 5) and retrospective (n = 21) studies[r]
14 Đọc thêm
Androgen-regulation of the protein tyrosine phosphatase PTPRR activates ERK1/2 signalling in prostate cancer cells
Androgens drive the onset and progression of prostate cancer (PCa) via androgen receptor (AR) signalling. The principal treatment for PCa is androgen deprivation therapy, although the majority of patients eventually develop a lethal castrate-resistant form of the disease, where despite low serum tes[r]
A COMPARATIVE STUDY ON THE EFFICACIES OF GONADOTROPIN-RELEASING HORMONE (GNRH) AGONIST AND GNRH ANTAGONIST IN NEOADJUVANT ANDROGEN DEPRIVATION THERAPY COMBINED WITH TRANSPERINEAL PROSTATE
Neoadjuvant androgen deprivation therapy (ADT) has been suggested to confer several clinical benefits in patients with prostate cancer (PCa) undergoing transperineal prostate brachytherapy (TPPB). Unlike gonadotropin-releasing hormone (GnRH) receptor agonists, a GnRH antagonist such as degarelix can[r]
BIOPRO-RCMI-1505 TRIAL: MULTICENTER STUDY EVALUATING THE USE OF A BIODEGRADABLE BALLOON FOR THE TREATMENT OF INTERMEDIATE RISK PROSTATE CANCER BY INTENSITY MODULATED RADIOTHERAPY; STUDY
Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity.
MOLECULAR CHESS? HALLMARKS OF ANTI-CANCER DRUG RESISTANCE
The development of resistance is a problem shared by both classical chemotherapy and targeted therapy. Patients may respond well at first, but relapse is inevitable for many cancer patients, despite many improvements in drugs and their use over the last 40 years.
8 Đọc thêm
INVESTIGATION OF THE FEASIBILITY OF ELECTIVE IRRADIATION TO NECK LEVEL IB USING INTENSITYMODULATED RADIOTHERAPY FOR PATIENTS WITH NASOPHARYNGEAL CARCINOMA: A RETROSPECTIVE ANALYSIS
To assess the feasibility of elective neck irradiation to level Ib in nasopharyngeal carcinoma (NPC) using intensity-modulated radiation therapy (IMRT). Methods: We retrospectively analyzed 1438 patients with newly-diagnosed, non-metastatic and biopsy-proven NPC treated with IMRT.
COMPARISON OF DETECTION METHODS AND FOLLOW-UP STUDY ON THE TYROSINE KINASE INHIBITORS THERAPY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ROS1 FUSION REARRANGEMENT
The screening of ROS proto-oncogene 1, receptor tyrosine kinase(ROS1) fusion rearrangement might be potentially beneficial for an effective therapy against non-small cell lung cancer (NSCLC). However, the three main ROS1 rearrangement detection methods have limitations, and no routine protocol for t[r]
SYSTEMIC THERAPY FOR HEPATOCELLULAR CARCINOMA: A REVIEW
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. Advanced HCC has poor prognosis with short survival rate. According to Barcelona Classification of Liver Cancer (BCLC), systemic therapy is optimal treatment for patients at this stage. In 2007, the targeted therapy with[r]
6 Đọc thêm
CRITICAL CARE OBSTETRICS PART 32 DOC
has not been recommended within 10 days of surgery or parturi-tion [193] . Recommended treatment schedules vary, but all consist of an IV loading dose followed by continuous infusion for 12 – 72 hours, depending on the clinical situation [192] . Thrombolytic therapy
10 Đọc thêm
Both comorbidity and worse performance status are associated with poorer overall survival after external beam radiotherapy for prostate cancer
In this retrospective study, we evaluated the biochemical recurrence rate, metastatic disease progression, and prostate cancer-specific and overall survival in patients curatively treated with external beam radiotherapy (EBRT) for early prostate cancer (PC).
SHORT GUIDE TO HEPATITIS C 4 POTX
40 | Hepatitis C Guide platelet counts. This limits the use of IFN in patients with advanced liver cirrhosis who are also more vulnerable to infections. The oral thrombopoietin receptor agonist eltrombopag has been tested in patients with chronic hepatitis C and li[r]
13 Đọc thêm
3D-IMAGE-GUIDED HDR-BRACHYTHERAPY VERSUS 2D HDR - BRACHYTHERAPY AFTER EXTERNAL BEAM RADIOTHERAPY FOR EARLY T-STAGE NASOPHARYNGEAL CARCINOMA
Two-dimensional high-dose-rate brachytherapy (2D-HDR-BT) is an effective method of dose escalation for local tumor control in early T-stage nasopharyngeal carcinoma (NPC). Treatment outcomes for 3D-image-guided high-dose-rate brachytherapy (3D-image-guided-HDR-BT) after external beam radiotherapy (E[r]
9 Đọc thêm